Clinical Trial Update: An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders [NA]

View source ↗

Summary

Open-label trial evaluating oxytocin in adolescents with autism spectrum disorders; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorders, Pervasive Developmental Disorders | NA | Status: COMPLETED | Results posted: 2023-10-04